Products
Online Inquiry
BNTA
Cat. No.:
OB0225WX-2007
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR, and LC-MS.
Size:
Add to basket
Product Overview
Description:
BNTA functions as a potent modulator of the extracellular matrix (ECM) that enhances the synthesis of cartilage structural molecules by inducing superoxide dismutase 3 (SOD3).
Synonym:
685119-25-9; N-[2-bromo-4-(phenylsulfonyl)-3-thienyl]-2-chlorobenzamide; N-[4-(benzenesulfonyl)-2-bromothiophen-3-yl]-2-chlorobenzamide; N-(2-bromo-4-(phenylsulfonyl)thiophen-3-yl)-2-chlorobenzamide
CAS No.:
685119-25-9
Compound CID:
2819453
Formula:
C17H11BrClNO3S2
Formula Weight:
456.76
Specification
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
BNTA is utilized in orthopedic research as a specialized small molecule to study the promotion of chondrogenesis and the enhancement of extracellular matrix production in cartilage repair.
Library Information
Target:
Reactive oxygen species
Receptor:
Reactive oxygen species
Pathways:
Metabolism; Immunology/Inflammation; NF-κB
Plate Number:
AOCL-26
Plate Location:
f10
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10mM DMSO
DMSO Max Solubility:
60 mg/mL; 131.36 mM
